18F-FDG PET/CT plays a unique role in the management of Takayasu arteritis patients with atypical manifestations

[31] Unizony S(2018)An increased major vessel uptake by 18F-FDG-PET/CT in NIH criteria inactive patients with Takayasu’s arteritis Clin Exp Rheumatol 36 99-30

[32] Arias-Urdaneta L(2018)Distribution patterns of 18F-fluorodeoxyglucose in large vessels of Takayasu’s and giant cell arteritis using positron emission tomography Clin Exp Rheumatol 36 24-187

[33] Miloslavsky E(2015)Recent advances in Takayasu’s arteritis Eur J Rheumatol 2 175-494

[34] Arvikar S(2018)Imaging modalities for the diagnosis and disease activity assessment of Takayasu’s arteritis: a systematic review and meta-analysis Autoimmun Rev 17 489-726

[35] Khosroshahi A(2015)Outcome of Takayasu arteritis with inactive disease at diagnosis: the extent of vascular involvement as a predictor of activation J Rheumatol 42 718-1295

[36] Keroack B(2018)Long-term outcome of 251 patients with Takayasu arteritis on combination immunosuppressant therapy: single centre experience from a large tertiary care teaching hospital in southern India Semin Arthritis Rheum 47 1289-1918

[37] Stone JR(2015)Impact of revascularization on hypertension in children with Takayasu's arteritis-induced renal artery stenosis: a 21-year review Pediatr Nephrol 30 1913-123

[38] Stone JH(2013)Long term results of endovascular treatment in renal arterial stenosis from Takayasu arteritis: angioplasty versus stent placement Eur J Radiol 82 117-undefined

[39] Santhosh S(2016)Selective stent placement versus balloon angioplasty for renovascular hypertension caused by Takayasu arteritis: two-year results Int J Cardiol 205 undefined-undefined

[40] Mittal BR(undefined)undefined undefined undefined undefined-undefined

[31] Unizony S(2018)An increased major vessel uptake by 18F-FDG-PET/CT in NIH criteria inactive patients with Takayasu’s arteritis Clin Exp Rheumatol 36 99-30

[32] Arias-Urdaneta L(2018)Distribution patterns of 18F-fluorodeoxyglucose in large vessels of Takayasu’s and giant cell arteritis using positron emission tomography Clin Exp Rheumatol 36 24-187

[33] Miloslavsky E(2015)Recent advances in Takayasu’s arteritis Eur J Rheumatol 2 175-494

[34] Arvikar S(2018)Imaging modalities for the diagnosis and disease activity assessment of Takayasu’s arteritis: a systematic review and meta-analysis Autoimmun Rev 17 489-726

[35] Khosroshahi A(2015)Outcome of Takayasu arteritis with inactive disease at diagnosis: the extent of vascular involvement as a predictor of activation J Rheumatol 42 718-1295

[36] Keroack B(2018)Long-term outcome of 251 patients with Takayasu arteritis on combination immunosuppressant therapy: single centre experience from a large tertiary care teaching hospital in southern India Semin Arthritis Rheum 47 1289-1918

[37] Stone JR(2015)Impact of revascularization on hypertension in children with Takayasu's arteritis-induced renal artery stenosis: a 21-year review Pediatr Nephrol 30 1913-123

[38] Stone JH(2013)Long term results of endovascular treatment in renal arterial stenosis from Takayasu arteritis: angioplasty versus stent placement Eur J Radiol 82 117-undefined

[39] Santhosh S(2016)Selective stent placement versus balloon angioplasty for renovascular hypertension caused by Takayasu arteritis: two-year results Int J Cardiol 205 undefined-undefined

[40] Mittal BR(undefined)undefined undefined undefined undefined-undefined